RRN3 and Parkinson disease: Similar to the human PD samples, TIF-IA mRNA in mouse ventral midbrain tissue was reduced at a clearly symptomatic stage (18 months) after a surprising transitory upregulation phase at 16 months (Fig. 4B; Fig. S5).